1	Analysis	Analysis	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	ligand-binding	ligand-binding	_	_	_	_	_	_	_
5	domain	domain	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	human	human	_	_	_	_	_	_	_
8	retinoic	retinoic	_	_	_	_	_	_	_
9	acid	acid	_	_	_	_	_	_	_
10	receptor	receptor	_	_	_	_	_	_	_
11	alpha	alpha	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	site-directed	site-directed	_	_	_	_	_	_	_
14	mutagenesis	mutagenesis	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Three	three	_	_	_	_	_	_	_
2	subtypes	subtype	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	retinoic	retinoic	_	_	_	_	_	_	_
5	acid	acid	_	_	_	_	_	_	_
6	receptors	receptor	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	RAR	RAR	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	termed	term	_	_	_	_	_	_	_
12	RAR	RAR	_	_	_	_	_	_	_
13	alpha	alpha	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	RAR	RAR	_	_	_	_	_	_	_
16	beta	beta	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	RAR	rar	_	_	_	_	_	_	_
20	gamma	gamma	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	have	have	_	_	_	_	_	_	_
23	been	be	_	_	_	_	_	_	_
24	described	describe	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	They	they	_	_	_	_	_	_	_
2	are	be	_	_	_	_	_	_	_
3	composed	compose	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	different	different	_	_	_	_	_	_	_
6	structural	structural	_	_	_	_	_	_	_
7	domains	domain	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	including	include	_	_	_	_	_	_	_
10	distinct	distinct	_	_	_	_	_	_	_
11	domains	domain	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	DNA	DNA	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	ligand	ligand	_	_	_	_	_	_	_
16	binding	binding	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	RARs	RAR	_	_	_	_	_	_	_
2	specifically	specifically	_	_	_	_	_	_	_
3	bind	bind	_	_	_	_	_	_	_
4	all-trans-retinoic	all-trans-retinoic	_	_	_	_	_	_	_
5	acid	acid	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	RA	RA	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	9-cis-RA	9-cis-RA	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	retinoid	retinoid	_	_	_	_	_	_	_
14	analogs	analog	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	examined	examine	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	functional	functional	_	_	_	_	_	_	_
9	role	role	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	cysteine	cysteine	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	arginine	arginine	_	_	_	_	_	_	_
14	residues	residue	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	ligand-binding	ligand-binding	_	_	_	_	_	_	_
18	domain	domain	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	hRAR	hRAR	_	_	_	_	_	_	_
21	alpha	alpha	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	hRAR	hRAR	_	_	_	_	_	_	_
24	alpha-LBD	alpha-lbd	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	amino	amino	_	_	_	_	_	_	_
27	acids	acid	_	_	_	_	_	_	_
28	154	154	_	_	_	_	_	_	_
29	to	to	_	_	_	_	_	_	_
30	462	462	_	_	_	_	_	_	_
31	)	)	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	All	all	_	_	_	_	_	_	_
2	conserved	conserve	_	_	_	_	_	_	_
3	cysteine	cysteine	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	arginine	arginine	_	_	_	_	_	_	_
6	residues	residue	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	this	this	_	_	_	_	_	_	_
9	domain	domain	_	_	_	_	_	_	_
10	were	be	_	_	_	_	_	_	_
11	mutated	mutate	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	site-directed	site-directed	_	_	_	_	_	_	_
14	mutagenesis	mutagenesis	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	mutant	mutant	_	_	_	_	_	_	_
19	proteins	protein	_	_	_	_	_	_	_
20	were	be	_	_	_	_	_	_	_
21	characterized	characterize	_	_	_	_	_	_	_
22	by	by	_	_	_	_	_	_	_
23	blocking	block	_	_	_	_	_	_	_
24	reactions	reaction	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	ligand-binding	ligand-binding	_	_	_	_	_	_	_
27	experiments	experiment	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	transactivation	transactivation	_	_	_	_	_	_	_
30	assays	assay	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	and	and	_	_	_	_	_	_	_
33	protease	protease	_	_	_	_	_	_	_
34	mapping	mapping	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	Changes	change	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	any	any	_	_	_	_	_	_	_
4	cysteine	cysteine	_	_	_	_	_	_	_
5	residue	residue	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	hRAR	hRAR	_	_	_	_	_	_	_
9	alpha-LBD	alpha-lbd	_	_	_	_	_	_	_
10	had	have	_	_	_	_	_	_	_
11	no	no	_	_	_	_	_	_	_
12	significant	significant	_	_	_	_	_	_	_
13	influence	influence	_	_	_	_	_	_	_
14	on	on	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	binding	binding	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	all-trans	all-trans	_	_	_	_	_	_	_
19	RA	RA	_	_	_	_	_	_	_
20	or	or	_	_	_	_	_	_	_
21	9-cis	9-cis	_	_	_	_	_	_	_
22	RA	RA	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Interestingly	interestingly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	residue	residue	_	_	_	_	_	_	_
4	C-235	c-235	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	specifically	specifically	_	_	_	_	_	_	_
7	important	important	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	antagonist	antagonist	_	_	_	_	_	_	_
10	binding	binding	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	With	with	_	_	_	_	_	_	_
2	respect	respect	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	arginine	arginine	_	_	_	_	_	_	_
5	residues	residue	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	only	only	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	two	two	_	_	_	_	_	_	_
10	single	single	_	_	_	_	_	_	_
11	mutations	mutation	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	R-276	R-276	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	R-394	r-394	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	alanine	alanine	_	_	_	_	_	_	_
18	showed	show	_	_	_	_	_	_	_
19	a	a	_	_	_	_	_	_	_
20	dramatic	dramatic	_	_	_	_	_	_	_
21	decrease	decrease	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	agonist	agonist	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	antagonist	antagonist	_	_	_	_	_	_	_
26	binding	binding	_	_	_	_	_	_	_
27	whereas	whereas	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	R272A	R272A	_	_	_	_	_	_	_
30	mutation	mutation	_	_	_	_	_	_	_
31	showed	show	_	_	_	_	_	_	_
32	only	only	_	_	_	_	_	_	_
33	a	a	_	_	_	_	_	_	_
34	slight	slight	_	_	_	_	_	_	_
35	effect	effect	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	For	for	_	_	_	_	_	_	_
2	all	all	_	_	_	_	_	_	_
3	other	other	_	_	_	_	_	_	_
4	arginine	arginine	_	_	_	_	_	_	_
5	mutations	mutation	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	no	no	_	_	_	_	_	_	_
8	differences	difference	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	affinity	affinity	_	_	_	_	_	_	_
11	were	be	_	_	_	_	_	_	_
12	detectable	detectable	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	two	two	_	_	_	_	_	_	_
3	mutations	mutation	_	_	_	_	_	_	_
4	R217A	R217A	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	R294A	R294A	_	_	_	_	_	_	_
7	caused	cause	_	_	_	_	_	_	_
8	an	an	_	_	_	_	_	_	_
9	increased	increase	_	_	_	_	_	_	_
10	binding	binding	_	_	_	_	_	_	_
11	efficiency	efficiency	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	antagonists	antagonist	_	_	_	_	_	_	_
14	but	but	_	_	_	_	_	_	_
15	no	no	_	_	_	_	_	_	_
16	change	change	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	agonist	agonist	_	_	_	_	_	_	_
19	binding	binding	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	From	from	_	_	_	_	_	_	_
2	these	these	_	_	_	_	_	_	_
3	results	result	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	can	can	_	_	_	_	_	_	_
7	conclude	conclude	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	electrostatic	electrostatic	_	_	_	_	_	_	_
10	interactions	interaction	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	retinoids	retinoid	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	RAR	RAR	_	_	_	_	_	_	_
16	alpha-LBD	alpha-lbd	_	_	_	_	_	_	_
17	play	play	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	significant	significant	_	_	_	_	_	_	_
20	role	role	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	ligand	ligand	_	_	_	_	_	_	_
23	binding	binding	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	antagonists	antagonist	_	_	_	_	_	_	_
5	show	show	_	_	_	_	_	_	_
6	distinctly	distinctly	_	_	_	_	_	_	_
7	different	different	_	_	_	_	_	_	_
8	requirements	requirement	_	_	_	_	_	_	_
9	for	for	_	_	_	_	_	_	_
10	efficient	efficient	_	_	_	_	_	_	_
11	binding	binding	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	which	which	_	_	_	_	_	_	_
14	may	may	_	_	_	_	_	_	_
15	contribute	contribute	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	their	their	_	_	_	_	_	_	_
18	interference	interference	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	ligand-inducible	ligand-inducible	_	_	_	_	_	_	_
22	transactivation	transactivation	_	_	_	_	_	_	_
23	function	function	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	RAR	RAR	_	_	_	_	_	_	_
26	alpha	alpha	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

